Skip to content

Penumbra PEN Japan — Revenue

Discontinued — last reported Q4 '19

Similar metrics at other companies

Nordson logo
NDSNJapan — Sales
$23.08M-7.5%
Exelixis logo
EXELJapan — Total revenues
$12.7M+129%
Krystal Biotech, Inc. logo
KRYSJapan — Product revenue, net
$8.19M
FormFactor logo
FORMJapan — Revenue
$8.28M-19.7%
Revvity logo
RVTYJAPAN — Revenue from Contract with Customer, Excluding Assessed Tax
$22.12M+7.3%
Allegro MicroSystems, Inc. logo
ALGMJP — Revenue
$41.87M+8.3%

Other financials

Income statement

See full
Revenue$374.8M+15.6%
Gross profit$253.4M+17.4%
Operating income$38.2M-5.2%
Net income$32.6M-16.9%
EPS (diluted)$0.82-18.0%

Balance sheet

See full
Cash & equivalents$241.3M-35.8%
Total debt$216.2M-2.0%
Total equity$1.5B+21.5%
Total assets$1.9B+19.2%

Cash flow

See full
Operating cash flow$87.0M+77.6%
CapEx$13.7M+1.5%
Free cash flow$73.3M+106%

Valuation

See full
Market cap$12.48B+25.1%
Enterprise value$12.45B+26.8%
P/E72.9×-163×
P/S8.6×+0.5×

Profitability

See full
Gross margin67.4%+3.7pp
Operating margin12.9%+9.8pp
Net margin11.8%+8.4pp
FCF margin14.6%+2.5pp

Returns & leverage

See full
Return on equity12.7%+9.2pp
Debt / equity0.1×0.0×
Current ratio-0.3×

Where this comes from

Reported directly by Penumbra in its filing.

Tagged under the XBRL concept us-gaap:Revenues.

The official record: Penumbra’s 10-K, filed February 26, 2020, on SEC EDGAR. View the filing →

Questions, answered.

What does japan — revenue mean?
The total revenue generated from sales of medical devices within the Japanese market.
How do you interpret japan — revenue?
An increase indicates successful market penetration, effective local sales execution, or favorable adoption of new product launches in Japan, while a decrease may signal competitive pressure, regulatory hurdles, or macroeconomic headwinds in the region.
How does japan — revenue compare across companies?
Comparable to international geographic segment revenues reported by other medical device companies, often evaluated based on regional market share and growth rates relative to the broader domestic market.